Is Palantir a Good Stock to Buy?
Palantir Technologies (PLTR) stock soared to its highest level in…
Sell
49
HUBB Quote, Financials, Valuation and Earnings
Last price:
$338.15
Seasonality move
:
3.73%
Day range:
$332.41 - $339.41
52-week range:
$330.32 - $481.35
Dividend yield:
1.5%
P/E ratio:
23.56x
P/S ratio:
3.25x
P/B ratio:
5.56x
Volume:
802.2K
Avg. volume:
703.7K
1-year change:
-18.47%
Market cap:
$18.2B
Revenue:
$5.6B
EPS (TTM):
$14.36
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $3.7B | $4.2B | $4.9B | $5.4B | $5.6B | |
| Revenue Growth (YoY) | -6.69% | 13.89% | 17.97% | 8.59% | 4.76% | |
| Cost of Revenues | $2.6B | $3B | $3.5B | $3.5B | $3.7B | |
| Gross Profit | $1.1B | $1.2B | $1.5B | $1.9B | $1.9B | |
| Gross Profit Margin | 29.49% | 27.46% | 29.74% | 35.14% | 33.83% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $591.3M | $619.2M | $762.5M | $849.6M | $812.5M | |
| Other Inc / (Exp) | -$9.9M | -$18.3M | -$2.5M | -$18.5M | -$12.5M | |
| Operating Expenses | $591.3M | $619.2M | $762.5M | $849.6M | $812.5M | |
| Operating Income | $494.5M | $532.3M | $709.1M | $1B | $1.1B | |
| Net Interest Expenses | $60.1M | $54.7M | $49.6M | $36.7M | $73.8M | |
| EBT. Incl. Unusual Items | $424.5M | $459.3M | $657M | $983.3M | $1B | |
| Earnings of Discontinued Ops. | $21.2M | $34.5M | $34.6M | -- | -- | |
| Income Tax Expense | $89.8M | $88.2M | $140.2M | $217.3M | $221.8M | |
| Net Income to Company | $334.7M | $371.1M | $516.8M | $766M | $783.5M | |
| Minority Interest in Earnings | -$4.7M | -$6.1M | -$5.5M | -$6.2M | -$5.7M | |
| Net Income to Common Excl Extra Items | $351.2M | $399.5M | $545.9M | $759.8M | $777.8M | |
| Basic EPS (Cont. Ops) | $6.46 | $7.33 | $10.13 | $14.14 | $14.46 | |
| Diluted EPS (Cont. Ops) | $6.43 | $7.28 | $10.07 | $14.05 | $14.37 | |
| Weighted Average Basic Share | $54.2M | $54.3M | $53.7M | $53.6M | $53.7M | |
| Weighted Average Diluted Share | $54.5M | $54.7M | $54.1M | $54M | $54M | |
| EBITDA | $629.1M | $663.1M | $855.1M | $1.2B | $1.3B | |
| EBIT | $484.6M | $514M | $706.6M | $1B | $1.1B | |
| Revenue (Reported) | $3.7B | $4.2B | $4.9B | $5.4B | $5.6B | |
| Operating Income (Reported) | $494.5M | $532.3M | $709.1M | $1B | $1.1B | |
| Operating Income (Adjusted) | $484.6M | $514M | $706.6M | $1B | $1.1B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $534.4M | $1.1B | $1.2B | $1.3B | $1.3B | |
| Revenue Growth (YoY) | 16.45% | 105.86% | 10.86% | 10.35% | -0.86% | |
| Cost of Revenues | $372.2M | $810.2M | $852.8M | $889.6M | $883.7M | |
| Gross Profit | $162.2M | $289.9M | $366.8M | $456.2M | $450.6M | |
| Gross Profit Margin | 30.35% | 26.35% | 30.08% | 33.9% | 33.77% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $80.9M | $155.6M | $194.8M | $230.6M | $192.5M | |
| Other Inc / (Exp) | $5.6M | $2.9M | -$3.5M | -$6.1M | $300K | |
| Operating Expenses | $80.9M | $155.6M | $194.8M | $230.6M | $192.5M | |
| Operating Income | $81.3M | $134.3M | $172M | $225.6M | $258.1M | |
| Net Interest Expenses | $14.3M | $13.3M | $11.7M | $10M | $14.2M | |
| EBT. Incl. Unusual Items | $72.6M | $123.9M | $156.8M | $209.5M | $244.2M | |
| Earnings of Discontinued Ops. | -- | $18.1M | -$18.3M | -- | -- | |
| Income Tax Expense | $11.3M | $22.6M | $32.9M | $37.1M | $46M | |
| Net Income to Company | $61.3M | $101.3M | $123.9M | $172.4M | $198.2M | |
| Minority Interest in Earnings | -$1.6M | -$1.8M | -$1M | -$1.4M | -$1.2M | |
| Net Income to Common Excl Extra Items | $80.9M | $117.6M | $104.6M | $171M | $197M | |
| Basic EPS (Cont. Ops) | $1.49 | $2.15 | $2.29 | $3.18 | $3.66 | |
| Diluted EPS (Cont. Ops) | $1.48 | $2.14 | $2.27 | $3.16 | $3.64 | |
| Weighted Average Basic Share | $54.5M | $54.3M | $53.4M | $53.6M | $53.7M | |
| Weighted Average Diluted Share | $54.8M | $54.7M | $54.1M | $54M | $54M | |
| EBITDA | $114.4M | $173.7M | $209.4M | $259.1M | $311.7M | |
| EBIT | $86.9M | $137.2M | $168.5M | $219.5M | $258.4M | |
| Revenue (Reported) | $534.4M | $1.1B | $1.2B | $1.3B | $1.3B | |
| Operating Income (Reported) | $81.3M | $134.3M | $172M | $225.6M | $258.1M | |
| Operating Income (Adjusted) | $86.9M | $137.2M | $168.5M | $219.5M | $258.4M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $3.7B | $4.2B | $4.9B | $5.4B | $5.6B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $2.6B | $3B | $3.5B | $3.5B | $3.7B | |
| Gross Profit | $1.1B | $1.2B | $1.5B | $1.9B | $1.9B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $591.3M | $619.2M | $762.5M | $849.6M | $812.5M | |
| Other Inc / (Exp) | -$9.9M | -$18.3M | -$2.5M | -$18.5M | -$12.5M | |
| Operating Expenses | $591.3M | $619.2M | $762.5M | $849.6M | $812.5M | |
| Operating Income | $494.5M | $532.3M | $709.1M | $1B | $1.1B | |
| Net Interest Expenses | $60.1M | $54.7M | $49.6M | $36.7M | $73.8M | |
| EBT. Incl. Unusual Items | $424.5M | $459.3M | $657M | $983.3M | $1B | |
| Earnings of Discontinued Ops. | -- | $34.5M | $34.6M | -- | -- | |
| Income Tax Expense | $89.8M | $88.2M | $140.2M | $217.3M | $221.8M | |
| Net Income to Company | $334.7M | $371.1M | $516.8M | $766M | $783.5M | |
| Minority Interest in Earnings | -$4.7M | -$6.1M | -$5.5M | -$6.2M | -$5.7M | |
| Net Income to Common Excl Extra Items | $351.2M | $399.5M | $545.9M | $759.8M | $777.8M | |
| Basic EPS (Cont. Ops) | $6.46 | $7.33 | $10.46 | $14.14 | $14.46 | |
| Diluted EPS (Cont. Ops) | $6.43 | $7.28 | $10.41 | $14.05 | $14.36 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $629.1M | $663.1M | $855.1M | $1.2B | $1.3B | |
| EBIT | $484.6M | $514M | $706.6M | $1B | $1.1B | |
| Revenue (Reported) | $3.7B | $4.2B | $4.9B | $5.4B | $5.6B | |
| Operating Income (Reported) | $494.5M | $532.3M | $709.1M | $1B | $1.1B | |
| Operating Income (Adjusted) | $484.6M | $514M | $706.6M | $1B | $1.1B | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $4.2B | $4.9B | $5.4B | $5.6B | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $3B | $3.5B | $3.5B | $3.7B | -- | |
| Gross Profit | $1.2B | $1.5B | $1.9B | $1.9B | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $619.2M | $762.5M | $849.6M | $812.5M | -- | |
| Other Inc / (Exp) | -$18.3M | -$2.5M | -$18.5M | -$12.5M | -- | |
| Operating Expenses | $619.2M | $762.5M | $849.6M | $812.5M | -- | |
| Operating Income | $532.3M | $709.1M | $1B | $1.1B | -- | |
| Net Interest Expenses | $54.7M | $49.6M | $36.7M | $73.8M | -- | |
| EBT. Incl. Unusual Items | $459.3M | $657M | $983.3M | $1B | -- | |
| Earnings of Discontinued Ops. | $34.5M | $34.6M | -- | -- | -- | |
| Income Tax Expense | $88.2M | $140.2M | $217.3M | $221.8M | -- | |
| Net Income to Company | $371.1M | $516.8M | $766M | $783.5M | -- | |
| Minority Interest in Earnings | -$6.1M | -$5.5M | -$6.2M | -$5.7M | -- | |
| Net Income to Common Excl Extra Items | $399.5M | $545.9M | $759.8M | $777.8M | -- | |
| Basic EPS (Cont. Ops) | $7.33 | $10.46 | $14.14 | $14.46 | -- | |
| Diluted EPS (Cont. Ops) | $7.28 | $10.41 | $14.05 | $14.36 | -- | |
| Weighted Average Basic Share | $217.1M | $214.8M | $214.4M | $214.8M | -- | |
| Weighted Average Diluted Share | $218.8M | $216.4M | $215.9M | $216.1M | -- | |
| EBITDA | $663.1M | $855.1M | $1.2B | $1.3B | -- | |
| EBIT | $514M | $706.6M | $1B | $1.1B | -- | |
| Revenue (Reported) | $4.2B | $4.9B | $5.4B | $5.6B | -- | |
| Operating Income (Reported) | $532.3M | $709.1M | $1B | $1.1B | -- | |
| Operating Income (Adjusted) | $514M | $706.6M | $1B | $1.1B | -- | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $258.6M | $286.2M | $440.5M | $336.1M | $329.1M | |
| Short Term Investments | $9.3M | $9.4M | $14.3M | $12.6M | $15.9M | |
| Accounts Receivable, Net | $574.1M | $695.7M | $778M | $805.5M | $780.1M | |
| Inventory | $526.7M | $662.1M | $740.7M | $832.9M | $841.8M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $71.8M | $66.8M | $84.3M | $129.7M | $146.5M | |
| Total Current Assets | $1.6B | $1.9B | $2B | $2.2B | $2.1B | |
| Property Plant And Equipment | $438.7M | $459.5M | $528M | $652.6M | $726.6M | |
| Long-Term Investments | $71.1M | $69.1M | $65.9M | $75.8M | $84.9M | |
| Goodwill | $1.9B | $1.9B | $2B | $2.5B | $2.5B | |
| Other Intangibles | $770.6M | $681.5M | $669.9M | $1.2B | $1.1B | |
| Other Long-Term Assets | $344M | $320.8M | $146.9M | $289M | $197.5M | |
| Total Assets | $5.1B | $5.3B | $5.4B | $6.9B | $6.7B | |
| Accounts Payable | $339.2M | $532.8M | $529.9M | $563.5M | $541.7M | |
| Accrued Expenses | $295.4M | $366.1M | $458.3M | $436.6M | $396.8M | |
| Current Portion Of Long-Term Debt | $3.1M | $9.7M | $4.7M | $17.4M | $2.4M | |
| Current Portion Of Capital Lease Obligations | $30.6M | $27.1M | $30.5M | $30.6M | $34.2M | |
| Other Current Liabilities | $79.7M | $91.3M | -- | $24.6M | -- | |
| Total Current Liabilities | $948.2M | $1.1B | $1.1B | $1.3B | $1.3B | |
| Long-Term Debt | $1.4B | $1.4B | $1.4B | $2B | $1.4B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $3B | $3B | $3B | $4B | $3.4B | |
| Common Stock | $600K | $600K | $600K | $600K | $600K | |
| Other Common Equity Adj | -$329.2M | -$330.8M | -$345.2M | -$312.4M | -$386.5M | |
| Common Equity | $2.1B | $2.2B | $2.4B | $2.9B | $3.3B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $15.4M | $10.9M | $9.7M | $12.3M | $14.4M | |
| Total Equity | $2.1B | $2.2B | $2.4B | $2.9B | $3.3B | |
| Total Liabilities and Equity | $5.1B | $5.3B | $5.4B | $6.9B | $6.7B | |
| Cash and Short Terms | $267.9M | $295.6M | $454.8M | $348.7M | $345M | |
| Total Debt | $1.6B | $1.4B | $1.4B | $2.1B | $1.6B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $258.6M | $286.2M | $440.5M | $336.1M | $329.1M | |
| Short Term Investments | $9.3M | $9.4M | $14.3M | $12.6M | $15.9M | |
| Accounts Receivable, Net | $574.1M | $695.7M | $778M | $805.5M | $780.1M | |
| Inventory | $526.7M | $662.1M | $740.7M | $832.9M | $841.8M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $71.8M | $66.8M | $84.3M | $129.7M | $146.5M | |
| Total Current Assets | $1.6B | $1.9B | $2B | $2.2B | $2.1B | |
| Property Plant And Equipment | $438.7M | $459.5M | $528M | $652.6M | $726.6M | |
| Long-Term Investments | $71.1M | $69.1M | $65.9M | $75.8M | $84.9M | |
| Goodwill | $1.9B | $1.9B | $2B | $2.5B | $2.5B | |
| Other Intangibles | $770.6M | $681.5M | $669.9M | $1.2B | $1.1B | |
| Other Long-Term Assets | $344M | $320.8M | $146.9M | $289M | $197.5M | |
| Total Assets | $5.1B | $5.3B | $5.4B | $6.9B | $6.7B | |
| Accounts Payable | $339.2M | $532.8M | $529.9M | $563.5M | $541.7M | |
| Accrued Expenses | $295.4M | $366.1M | $458.3M | $436.6M | $396.8M | |
| Current Portion Of Long-Term Debt | $3.1M | $9.7M | $4.7M | $17.4M | $2.4M | |
| Current Portion Of Capital Lease Obligations | $30.6M | $27.1M | $30.5M | $30.6M | $34.2M | |
| Other Current Liabilities | $79.7M | $91.3M | -- | $24.6M | -- | |
| Total Current Liabilities | $948.2M | $1.1B | $1.1B | $1.3B | $1.3B | |
| Long-Term Debt | $1.4B | $1.4B | $1.4B | $2B | $1.4B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $3B | $3B | $3B | $4B | $3.4B | |
| Common Stock | $600K | $600K | $600K | $600K | $600K | |
| Other Common Equity Adj | -$329.2M | -$330.8M | -$345.2M | -$312.4M | -$386.5M | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $15.4M | $10.9M | $9.7M | $12.3M | $14.4M | |
| Total Equity | $2.1B | $2.2B | $2.4B | $2.9B | $3.3B | |
| Total Liabilities and Equity | $5.1B | $5.3B | $5.4B | $6.9B | $6.7B | |
| Cash and Short Terms | $267.9M | $295.6M | $454.8M | $348.7M | $345M | |
| Total Debt | $1.6B | $1.4B | $1.4B | $2.1B | $1.6B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $334.7M | $371.1M | $516.8M | $766M | $783.5M | |
| Depreciation & Amoritzation | $144.5M | $149.1M | $148.5M | $149.7M | $212.1M | |
| Stock-Based Compensation | $21.9M | $17.5M | $24.5M | $26.5M | $30.6M | |
| Change in Accounts Receivable | $41.7M | -$124.8M | -$66.8M | -$1.6M | $22.2M | |
| Change in Inventories | $45.8M | -$138.9M | -$66.5M | -$42.1M | -$22.7M | |
| Cash From Operations | $648M | $543.8M | $583.2M | $880.8M | $991.2M | |
| Capital Expenditures | $82.8M | $90.2M | $129.3M | $165.7M | $180.4M | |
| Cash Acquisitions | -$239.6M | $8.6M | $155.7M | -$1.2B | $128.8M | |
| Cash From Investing | -$328.8M | -$77.8M | $16.4M | -$1.4B | -$59.1M | |
| Dividends Paid (Ex Special Dividend) | -$201.4M | -$216.9M | -$229.6M | -$245.5M | -$267.3M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $350.5M | $306.8M | -- | $700M | $22.9M | |
| Long-Term Debt Repaid | -$334.9M | -$467.6M | -$4.8M | -$2.2M | -$600M | |
| Repurchase of Common Stock | -$41.3M | -$11.2M | -$182M | -$30M | -$40M | |
| Other Financing Activities | -$17.1M | -$44.1M | -$20.7M | -$33.8M | -$39M | |
| Cash From Financing | -$244.2M | -$433M | -$437.1M | $388.5M | -$923.4M | |
| Beginning Cash (CF) | $179.8M | $258.6M | $286.2M | $440.5M | $336.1M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $75M | $33M | $162.5M | -$110.9M | $8.7M | |
| Ending Cash (CF) | $258.6M | $286.2M | $440.5M | $336.1M | $329.1M | |
| Levered Free Cash Flow | $565.2M | $453.6M | $453.9M | $715.1M | $810.8M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $61.3M | $101.3M | $123.9M | $172.4M | $198.2M | |
| Depreciation & Amoritzation | $27.5M | $36.5M | $40.9M | $39.6M | $53.3M | |
| Stock-Based Compensation | $1.9M | $1.9M | $2.8M | $4.9M | $6.4M | |
| Change in Accounts Receivable | $83.8M | $20.3M | $67.6M | $99.4M | $138.2M | |
| Change in Inventories | $700K | -$47.5M | $1.3M | -$2.7M | $8.1M | |
| Cash From Operations | $192.4M | $237M | $239.5M | $345.5M | $432.4M | |
| Capital Expenditures | $31.1M | $27.4M | $62.1M | $61.9M | $68M | |
| Cash Acquisitions | -$237.6M | -- | -$13.5M | -$1.2B | -- | |
| Cash From Investing | -$282.4M | -$24.3M | -$74.5M | -$1.2B | -$79.1M | |
| Dividends Paid (Ex Special Dividend) | -$53.2M | -$57.1M | -$60M | -$65.4M | -$70.8M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $125.5M | $8.1M | -- | -- | -- | |
| Long-Term Debt Repaid | -$3.6M | -$127.4M | $600K | -$2.2M | -$213.7M | |
| Repurchase of Common Stock | -- | -- | -$32M | -- | -$10M | |
| Other Financing Activities | -$5.8M | -$4.2M | -$5.4M | -$3.6M | -$1.8M | |
| Cash From Financing | $71.9M | -$180.6M | -$96.8M | $630.2M | -$447M | |
| Beginning Cash (CF) | $269.2M | $257.9M | $366.9M | $572.8M | $435.7M | |
| Foreign Exchange Rate Adjustment | $8.5M | -$500K | $5.4M | $6.6M | -$13.2M | |
| Additions / Reductions | -$18.1M | $32.1M | $68.2M | -$243.1M | -$93.7M | |
| Ending Cash (CF) | $258.6M | $286.2M | $440.5M | $336.1M | $329.1M | |
| Levered Free Cash Flow | $161.3M | $209.6M | $177.4M | $283.6M | $364.4M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $334.7M | $371.1M | $516.8M | $766M | $783.5M | |
| Depreciation & Amoritzation | $144.5M | $149.1M | $148.5M | $149.7M | $212.1M | |
| Stock-Based Compensation | $21.9M | $17.5M | $24.5M | $26.5M | $30.6M | |
| Change in Accounts Receivable | $41.7M | -$124.8M | -$66.8M | -$1.6M | $22.2M | |
| Change in Inventories | $45.8M | -$138.9M | -$66.5M | -$42.1M | -$22.7M | |
| Cash From Operations | $648M | $543.8M | $583.2M | $880.8M | $991.2M | |
| Capital Expenditures | $82.8M | $90.2M | $129.3M | $165.7M | $180.4M | |
| Cash Acquisitions | -$239.6M | $8.6M | $155.7M | -$1.2B | $128.8M | |
| Cash From Investing | -$328.8M | -$77.8M | $16.4M | -$1.4B | -$59.1M | |
| Dividends Paid (Ex Special Dividend) | -$201.4M | -$216.9M | -$229.6M | -$245.5M | -$267.3M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $350.5M | $306.8M | -- | -- | -- | |
| Long-Term Debt Repaid | -$334.9M | -$467.6M | -- | -$2.2M | -$600M | |
| Repurchase of Common Stock | -$41.3M | -$11.2M | -$182M | -$30M | -$40M | |
| Other Financing Activities | -$17.1M | -$44.1M | -$20.7M | -$33.8M | -$39M | |
| Cash From Financing | -$244.2M | -$433M | -$437.1M | $388.5M | -$923.4M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $75M | $33M | $162.5M | -$110.9M | $8.7M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $565.2M | $453.6M | $453.9M | $715.1M | $810.8M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $371.1M | $516.8M | $766M | $783.5M | -- | |
| Depreciation & Amoritzation | $149.1M | $148.5M | $149.7M | $212.1M | -- | |
| Stock-Based Compensation | $17.5M | $24.5M | $26.5M | $30.6M | -- | |
| Change in Accounts Receivable | -$124.8M | -$66.8M | -$1.6M | $22.2M | -- | |
| Change in Inventories | -$138.9M | -$66.5M | -$42.1M | -$22.7M | -- | |
| Cash From Operations | $543.8M | $583.2M | $880.8M | $991.2M | -- | |
| Capital Expenditures | $90.2M | $129.3M | $165.7M | $180.4M | -- | |
| Cash Acquisitions | $8.6M | $155.7M | -$1.2B | $128.8M | -- | |
| Cash From Investing | -$77.8M | $16.4M | -$1.4B | -$59.1M | -- | |
| Dividends Paid (Ex Special Dividend) | -$216.9M | -$229.6M | -$245.5M | -$267.3M | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $306.8M | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$467.6M | -$4.8M | -$2.2M | -$600M | -- | |
| Repurchase of Common Stock | -$11.2M | -$182M | -$30M | -$40M | -- | |
| Other Financing Activities | -$44.1M | -$20.7M | -$33.8M | -$39M | -- | |
| Cash From Financing | -$433M | -$437.1M | $388.5M | -$923.4M | -- | |
| Beginning Cash (CF) | $1.2B | $1.4B | $1.9B | $1.6B | -- | |
| Foreign Exchange Rate Adjustment | -$3M | -$8.8M | $6.9M | -$16.4M | -- | |
| Additions / Reductions | $33M | $162.5M | -$110.9M | $8.7M | -- | |
| Ending Cash (CF) | $1.2B | $1.6B | $1.8B | $1.6B | -- | |
| Levered Free Cash Flow | $453.6M | $453.9M | $715.1M | $810.8M | -- | |
Get HUBB Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
HUBB
Sector
P/E ratio
23.56x
17.55x
PEG ratio
10.68x
0.28x
P/B ratio
5.56x
1.69x
Price / LTM sales
3.25x
0.89x
Growth Metrics
HUBB
Sector
Revenue growth
-0.86%
3.05%
Earnings growth
15.19%
6.36%
Revenue (5-year growth)
7.36%
4.43%
Earnings forecast
$4.02
$0.36
Profitability
HUBB
Sector
Profitability FY 2024
$1.9B
$409.9M
Return on invested capital
15.45%
5.7%
Return on assets
11.35%
3.56%
Return on equity
25.24%
8.62%
Earnings Date
Last Earnings Date
Feb
4
Next Earnings Date
Apr
30
Estimated Next Earnings Date
May
6
Balance Sheet
HUBB
Sector
Total cash
$345M
$163.9M
Short term investments
$15.9M
$42.1M
Total assets
$6.7B
$1.9B
Long term debt
$1.6B
$272.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Is Sportradar Stock Going Up?
Sportradar (NASDAQ:SRAD) should be on your radar for a stock…
Is Roblox Stock a Buy, Sell or Hold?
Gaming company Roblox (NYSE:RBLX) operates a massive platform that allows…
Stock Ideas
Buy
55
Is AAPL Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 36x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Buy
51
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 40x
Alerts
Sell
50
RGC alert for Mar 22
Regencell Bioscience Holdings [RGC] is up 27.82% over the past day.
Sell
36
VMI alert for Mar 22
Valmont Industries [VMI] is down 12.54% over the past day.
Buy
61
ALNY alert for Mar 22
Alnylam Pharmaceuticals [ALNY] is up 11.7% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
